Skip to main content
. 2012 Feb 25;385(6):641–650. doi: 10.1007/s00210-012-0732-4

Fig. 2.

Fig. 2

Concentration-dependent anti-aggregatory effects of CORM-3 and CORM-A1 in human PRP (a) (n = 4–52), human WP (b) (n = 4–39), and human whole blood in vitro (c) (n = 3–9)